Research

Physicians' Undecided Attitudes Toward Posthumous Reproduction: Fertility Preservation in Cancer Patients with a Poor Prognosis

Although some health care providers have questioned the importance of fertility loss in the context of a cancer diagnosis, research shows that cancer survivors desire a return to normal life post treatment; they are very much concerned with fertility loss and are interested in FP options.



 

Original research

Physicians' Undecided Attitudes Toward Posthumous Reproduction: Fertility Preservation in Cancer Patients with a Poor Prognosis

  • Gwendolyn P. Quinn, PhD; Caprice A. Knapp, PhD; Teri L. Malo, PhD; Jessica McIntyre, BA; Paul B. Jacobsen, PhD; Susan T. Vadaparampil, PhD

    Abstract

    Background

    The American Society for Clinical Oncology (ASCO) established guidelines for fertility preservation for cancer patients. In a national study of US oncologists, we examined attitudes toward the use of fertility preservation among patients with a poor prognosis, focusing on attitudes toward posthumous reproduction.

    Method

    A cross-sectional survey was administered via mail and Internet to a stratified random sample of US oncologists. The survey measured demographics, knowledge, attitude, and practice behaviors regarding posthumous reproduction and fertility preservation with cancer patients of childbearing age.

    Results

    Only 16.2% supported posthumous parenting, whereas the majority (51.5%) did not have an opinion. Analysis of variance indicated that attitudes toward posthumous reproduction were significantly related to physician practice behaviors and were dependent on oncologists' knowledge of ASCO guidelines.

    Conclusions

    Physician attitudes may conflict with the recommended guidelines and may reduce the likelihood that some patients will receive information about fertility preservation. Further education may raise physicians' awareness of poor-prognostic patients' interest in pursuing this technology.

    *For a PDF of the full article click in the link to the left of this introduction.

Recommended Reading

Did the IOM Get Vitamin D Targets Wrong?
MDedge Hematology and Oncology
Hodgkin's Survivors Face High Breast Cancer Risk
MDedge Hematology and Oncology
Duloxetine Eases Pain of Chemo-Induced Neuropathy
MDedge Hematology and Oncology
Less Zoledronic Acid May Work in Breast Cancer
MDedge Hematology and Oncology
Chemotherapy-Induced Neuropathy Linked to Falls
MDedge Hematology and Oncology
Vitamin D Eases Aromatase Inhibitor-Related Arthralgia
MDedge Hematology and Oncology
Tips on Cardiovascular Testing Before Cancer Surgery
MDedge Hematology and Oncology
Central Nervous System Complications of Cancer Therapy
MDedge Hematology and Oncology
What Can I Do? Recommendations for Responding to Issues Identified by Patient-Reported Outcomes Assessments Used in Clinical Practice
MDedge Hematology and Oncology
Chemotherapy-induced nausea and vomiting in Asian women with breast cancer receiving anthracycline-based adjuvant chemotherapy
MDedge Hematology and Oncology